| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-147 |
Sentence |
denotes |
New high-performance liquid chromatography assay for glycosyltransferases based on derivatization with anthranilic acid and fluorescence detection. |
| T1 |
0-147 |
Sentence |
denotes |
New high-performance liquid chromatography assay for glycosyltransferases based on derivatization with anthranilic acid and fluorescence detection. |
| T1 |
0-147 |
Sentence |
denotes |
New high-performance liquid chromatography assay for glycosyltransferases based on derivatization with anthranilic acid and fluorescence detection. |
| TextSentencer_T2 |
148-449 |
Sentence |
denotes |
Assays were developed using the unique labeling chemistry of 2-aminobenzoic acid (2AA; anthranilic acid, AA) for measuring activities of both β1-4 galactosyltransferase (GalT-1) and α2-6 sialyltransferase (ST-6) by high-performance liquid chromatography (HPLC) with fluorescence detection (Anumula KR. |
| T2 |
148-449 |
Sentence |
denotes |
Assays were developed using the unique labeling chemistry of 2-aminobenzoic acid (2AA; anthranilic acid, AA) for measuring activities of both β1-4 galactosyltransferase (GalT-1) and α2-6 sialyltransferase (ST-6) by high-performance liquid chromatography (HPLC) with fluorescence detection (Anumula KR. |
| T2 |
148-449 |
Sentence |
denotes |
Assays were developed using the unique labeling chemistry of 2-aminobenzoic acid (2AA; anthranilic acid, AA) for measuring activities of both β1-4 galactosyltransferase (GalT-1) and α2-6 sialyltransferase (ST-6) by high-performance liquid chromatography (HPLC) with fluorescence detection (Anumula KR. |
| TextSentencer_T3 |
450-455 |
Sentence |
denotes |
2006. |
| T3 |
450-455 |
Sentence |
denotes |
2006. |
| T3 |
450-455 |
Sentence |
denotes |
2006. |
| TextSentencer_T4 |
456-587 |
Sentence |
denotes |
Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates. |
| T4 |
456-587 |
Sentence |
denotes |
Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates. |
| T4 |
456-587 |
Sentence |
denotes |
Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates. |
| TextSentencer_T5 |
588-601 |
Sentence |
denotes |
Anal Biochem. |
| T5 |
588-601 |
Sentence |
denotes |
Anal Biochem. |
| T5 |
588-612 |
Sentence |
denotes |
Anal Biochem. 350:1-23). |
| TextSentencer_T6 |
602-612 |
Sentence |
denotes |
350:1-23). |
| T6 |
602-612 |
Sentence |
denotes |
350:1-23). |
| TextSentencer_T7 |
613-837 |
Sentence |
denotes |
N-Acetylglucosamine (GlcNAc) and N-acetyllactosamine were used as acceptors and uridine diphosphate (UDP)-galactose and cytidine monophosphate (CMP)-N-acetylneuraminic acid (NANA) as donors for GalT-1 and ST-6, respectively. |
| T6 |
613-837 |
Sentence |
denotes |
N-Acetylglucosamine (GlcNAc) and N-acetyllactosamine were used as acceptors and uridine diphosphate (UDP)-galactose and cytidine monophosphate (CMP)-N-acetylneuraminic acid (NANA) as donors for GalT-1 and ST-6, respectively. |
| T7 |
613-837 |
Sentence |
denotes |
N-Acetylglucosamine (GlcNAc) and N-acetyllactosamine were used as acceptors and uridine diphosphate (UDP)-galactose and cytidine monophosphate (CMP)-N-acetylneuraminic acid (NANA) as donors for GalT-1 and ST-6, respectively. |
| TextSentencer_T8 |
838-981 |
Sentence |
denotes |
Enzymatic products were labeled in situ with AA and were separated from the substrates on TSKgel Amide 80 column using normal-phase conditions. |
| T7 |
838-981 |
Sentence |
denotes |
Enzymatic products were labeled in situ with AA and were separated from the substrates on TSKgel Amide 80 column using normal-phase conditions. |
| T8 |
838-981 |
Sentence |
denotes |
Enzymatic products were labeled in situ with AA and were separated from the substrates on TSKgel Amide 80 column using normal-phase conditions. |
| TextSentencer_T9 |
982-1134 |
Sentence |
denotes |
Enzyme units were determined from the peak areas by comparison with the concomitantly derivatized standards Gal-β1-4GlcNAc and NANA-α2-6 Gal-β1-4GlcNAc. |
| T8 |
982-1134 |
Sentence |
denotes |
Enzyme units were determined from the peak areas by comparison with the concomitantly derivatized standards Gal-β1-4GlcNAc and NANA-α2-6 Gal-β1-4GlcNAc. |
| T9 |
982-1134 |
Sentence |
denotes |
Enzyme units were determined from the peak areas by comparison with the concomitantly derivatized standards Gal-β1-4GlcNAc and NANA-α2-6 Gal-β1-4GlcNAc. |
| TextSentencer_T10 |
1135-1264 |
Sentence |
denotes |
Linearity (time and enzyme concentration), precision (intra- and interassay) and reproducibility for the assays were established. |
| T9 |
1135-1264 |
Sentence |
denotes |
Linearity (time and enzyme concentration), precision (intra- and interassay) and reproducibility for the assays were established. |
| T10 |
1135-1264 |
Sentence |
denotes |
Linearity (time and enzyme concentration), precision (intra- and interassay) and reproducibility for the assays were established. |
| TextSentencer_T11 |
1265-1370 |
Sentence |
denotes |
The assays were found to be useful in monitoring the enzyme activities during isolation and purification. |
| T10 |
1265-1370 |
Sentence |
denotes |
The assays were found to be useful in monitoring the enzyme activities during isolation and purification. |
| T11 |
1265-1370 |
Sentence |
denotes |
The assays were found to be useful in monitoring the enzyme activities during isolation and purification. |
| TextSentencer_T12 |
1371-1495 |
Sentence |
denotes |
The assays were highly sensitive and performed equal to or better than the traditional radioactive sugar-based measurements. |
| T11 |
1371-1495 |
Sentence |
denotes |
The assays were highly sensitive and performed equal to or better than the traditional radioactive sugar-based measurements. |
| T12 |
1371-1495 |
Sentence |
denotes |
The assays were highly sensitive and performed equal to or better than the traditional radioactive sugar-based measurements. |
| TextSentencer_T13 |
1496-1657 |
Sentence |
denotes |
The assay format can also be used for measuring the activity of other transferases, provided that the carbohydrate acceptors contain a reducing end for labeling. |
| T12 |
1496-1657 |
Sentence |
denotes |
The assay format can also be used for measuring the activity of other transferases, provided that the carbohydrate acceptors contain a reducing end for labeling. |
| T13 |
1496-1657 |
Sentence |
denotes |
The assay format can also be used for measuring the activity of other transferases, provided that the carbohydrate acceptors contain a reducing end for labeling. |
| TextSentencer_T14 |
1658-1718 |
Sentence |
denotes |
An assay for glycoprotein acceptors was developed using IgG. |
| T13 |
1658-1718 |
Sentence |
denotes |
An assay for glycoprotein acceptors was developed using IgG. |
| T14 |
1658-1718 |
Sentence |
denotes |
An assay for glycoprotein acceptors was developed using IgG. |
| TextSentencer_T15 |
1719-1931 |
Sentence |
denotes |
A short HPLC profiling method was developed for the separation of IgG glycans (biantennary G0, G1, G2, mono- and disialylated), which facilitated the determination of GalT-1 and ST-6 activities in a rapid manner. |
| T14 |
1719-1931 |
Sentence |
denotes |
A short HPLC profiling method was developed for the separation of IgG glycans (biantennary G0, G1, G2, mono- and disialylated), which facilitated the determination of GalT-1 and ST-6 activities in a rapid manner. |
| T15 |
1719-1931 |
Sentence |
denotes |
A short HPLC profiling method was developed for the separation of IgG glycans (biantennary G0, G1, G2, mono- and disialylated), which facilitated the determination of GalT-1 and ST-6 activities in a rapid manner. |
| TextSentencer_T16 |
1932-2050 |
Sentence |
denotes |
Furthermore, this profiling method should prove useful for monitoring the changes in IgG glycans in clinical settings. |
| T15 |
1932-2050 |
Sentence |
denotes |
Furthermore, this profiling method should prove useful for monitoring the changes in IgG glycans in clinical settings. |
| T16 |
1932-2050 |
Sentence |
denotes |
Furthermore, this profiling method should prove useful for monitoring the changes in IgG glycans in clinical settings. |